Zoom Outage Triggers A Lot Of Porn Viewing

When there’s a Zoom outage, people turn to Pornhub. Who’s surprised?

The post Zoom Outage Triggers A Lot Of Porn Viewing appeared first on The Fresh Toast.

According to a new study published in the American Journal of Public Health, intravenous opioid users who routinely consume cannabis are more likely to cease their injections, and to do so more rapidly than IV users who don’t use weed. 

An investigative team with the British Columbia Centre on Substance Use reached their conclusions by studying the correlation between cannabis consumption and IV drug use in a sample group of more than 2,000 participants.

In addition to determining that regular weed use corresponded to “swifter rates” of giving up injections, the study also found that cannabis did not increase the subjects’ tendency toward relapse.

“In the adjusted analysis, at-least-daily cannabis use was significantly associated with increased rates of injection cessation” the study reports. “To our knowledge, this is the first longitudinal study to identify a positive association between cannabis use and cessation of injection drug use.”

A number of prior research projects have highlighted how cannabis scientifically helps chronic pain patients veer away from opioids, but this is among the first to be conducted specifically on a population of IV drug users.

“These observations are encouraging given the uncertainty surrounding the impact of cannabis legalization policies during the ongoing opioid overdose crisis… particularly among PWID [people who inject drugs],” the study states. “The accumulating evidence… linking cannabis use to opioid use behaviors further supports the evaluation of the therapeutic benefits of cannabis and specific cannabinoids (e.g., CBD and THC) for people living with opioid use disorder.”

Last year, researchers at New York’s Mount Sinai Hospital gathered clinical data that determined CBD reduced cravings and alleviated anxiety among heroin users. The team assessed the impact of a CBD-versus-placebo study involving 42 drug-abstinent subjects who had used heroin in the past. Participants who got CBD reported unmistakable relief.

The final results, published in the American Journal of Psychiatry, concluded, “CBD’s potential to reduce cue-induced craving and anxiety provides a strong basis for further investigation of this phytocannabinoid as a treatment option for opioid use disorder.”

Kamala Harris Vs. Rudy Giuliani: Who Was Worse On Marijuana?

Giuliani sparked the match that lit a bonfire while Harris has used her power to put out whatever flames she caused. You decide who was a bigger opponent to cannabis.

The post Kamala Harris Vs. Rudy Giuliani: Who Was Worse On Marijuana? appeared first on The Fresh Toast.

These Google Queries Set A Record High During Peak Pandemic

A news study shows that the pandemic prompted many to turn to Google for some self-diagnosis during lockdown.  

The post These Google Queries Set A Record High During Peak Pandemic appeared first on The Fresh Toast.

Cannabis may be a viable treatment for opioid addiction, according to a new study.

Quest reported that cannabis “continues to top the list of the most commonly detected illicit substances across all workforce categories.”

Depression Attracts Frequent Marijuana Users, And Could Worsen Symptoms

A new study found people with depression were double the risk of using marijuana than those without, and were more likely to consume at a near-daily rate.

The post Depression Attracts Frequent Marijuana Users, And Could Worsen Symptoms appeared first on The Fresh Toast.

The loss of an elder herd member has triggered stress and grief in an elephant living in a zoo in Warsaw. Specialists are going to try to treat her with CBD.

A new independent study by Leafreport has found that the CBD beverage industry has some serious quality control issues.

To conduct their investigation, Leafreport partnered with Canalysis Laboratories, a licensed cannabis testing facility based in Las Vegas. The companies analyzed 22 CBD beverages from 20 major national brands to determine the exact CBD content of the drinks. The results were less than promising, with more than half of all drinks containing less cannabinoid content than they claimed.

Out of all 22 drinks, only four matched the CBD content advertised on the label — within an acceptable threshold of 10 percent. Twelve of these drinks (54 percent of all tested products) contained less CBD than advertised. One drink had around 20 percent less CBD than advertised, nine products had 30 percent less CBD, and two products actually had no CBD in them at all.

Six of the drinks contained more CBD than stated on the label as well, and one of these contained more than 30 percent more CBD than what was claimed. In all, 81 percent of all products differed from their advertised CBD content by more than 10 percent, and 61 percent of the products differed from their labels by over 40 percent. 

Leafreport noted that they expected to see large discrepancies in their testing, “because CBD beverages are difficult to formulate and contain relatively small amounts of CBD, which means that variations of even a few milligrams (mg) can have a big effect.” The study also found no link between each brand’s reputation and the quality control of their products. Lesser-known brands were found to be just as inaccurately labeled as more popular drinks. 

The Farm Bill legalized hemp and all of its byproducts at the end of 2018. But, the legislation only really legalized pure CBD oils, and the US Food and Drug Administration (FDA) made it clear that infused drinks and foods would remain illegal until it developed regulations to cover these products. Twenty months later, those regulations have yet to arrive. The FDA is currently hiring people to study CBD products, however, so the regulations may finally be on their way.

Regardless of the law, companies have flooded the market with thousands of CBD drinks, foods, lotions, lubes, and pretty much any other product you can think of. But since federal regulations have yet to be established, CBD companies are under no obligation to actually stick to the content guidelines that they advertise.

Other studies have found that mislabeling is common throughout the entire CBD industry, and not just the infused beverage sector. A 2019 investigation found that many CBD products contained illegal THC levels, including one with a highly psychoactive THC content of 30 percent. A 2017 study found that two-thirds of all CBD extracts in Pennsylvania were inaccurately labeled, and a UK study also found that over half of all CBD products did not match the cannabinoid content advertised on their labels.

Labor Day Highlights Cannabis Union Controversy

With unionization becoming ever more common in the cannabis industry, Labor Day 2020 provides an opportunity to take a closer look at the state of cannabis labor unions in the U.S.. 

The post Labor Day Highlights Cannabis Union Controversy appeared first on The Fresh Toast.